Bhavana Joneja joined Heller Ehrman in 2007 and is an associate in the Intellectual Property Litigation Practice Group. Her practice primarily focuses on patent litigation.
Experience
Ms. Joneja’s litigation experience includes active participation in the development of litigation strategies, brief writing, all facets of fact and expert discovery and trial preparation. She has represented clients in matters involving several technical subject matters, including pharmaceutical compositions, chemicals and biomedical devices. In addition, she has prosecuted numerous patent applications, prepared patentability and non-infringement opinions, and has experience with European patent oppositions involving biotechnology and biopharmaceuticals.
Education
University of Delaware (B.S., Biochemistry, 1994, Howard Hughes Research Initiative Grant); Pennsylvania State University (Ph.D., Biochemistry, Microbiology & Molecular Biology, 1998, Sigma Xi Grants-in-Aid of Research and the Pela Fay Braucher Scholarship); Fordham Law School (J.D., 2003).
Admissions & Courts
New York, New Jersey, New York Eastern District Court, New York Southern District Court, Court of Appeals for the Federal Circuit, U.S. Patent and Trademark Office.
Memberships
American Bar Association; American Intellectual Property Bar Association; New York Intellectual Property Law Association.
Representative Engagements
Prior to joining Heller Ehrman
IP Litigation:
Represented the defendant in patent litigation involving technology for monitoring and surveillance of computer networks for intrusion detection. Actively participated in all facets of discovery, including depositions, pretrial preparation and successful summary judgment submission. SRI International Inc. v. Internet Security Systems, Inc. (D. Del.).
District court and appellate counsel for GeneOhm Sciences and Becton, Dickinson and Company regarding an application by bioMerieux under 28 U.S.C. § 1782 to take discovery in the U.S. for use in foreign proceedings relating to intellectual property rights to methicillin-resistant Staph aureus (MRSA) detection technology. bioMerieux SA and bioMerieux, Inc. v. GeneOhm Sciences, Inc., Infectio Diagnostic (I.D.I.), Inc. and Becton, Dickinson and Company (S.D. Cal. and 9th Cir.).
Represented the patentee and a large medical device manufacturer in patent litigation regarding vascular stents. Actively participated in all facets of discovery, including depositions. Dr. David Goldfarb and C. R. Bard Inc. v. W. L. Gore & Associates, Inc. (D. Ariz.).
Represented manufacturer and retailer of a broad line of nutritional supplements in a patent litigation involving methods for making smaller tablets. Actively participated in all facets of discovery, including brief writing. Rexall Sundown, Inc. v. Weider Nutrition International, Inc. and Leiner Health Products, Inc. (W.D. Wis.).
Counsel for Becton, Dickinson and Company in an action for alleged patent infringement and breach of a licensing agreement. Wardlaw v. Becton, Dickinson and Company (D. Conn.).
Appellate counsel for a knee-brace manufacturer appealing from an adverse jury verdict of patent infringement. Medical Technology, Inc. (d/b/a Bledsoe Brace Systems) v. Generation II Orthotics Inc. (Fed. Cir.)
Counsel for Becton, Dickinson and Company in an action for correction of inventorship. Becton, Dickinson and Company v. Med-Design Corp. (D. Del.).
Defended a biopharmaceutical company in a patent litigation regarding phage display. Actively participated in all facets of discovery, including brief writing and depositions. George Pieczenik and I.C. Technologies America, Inc. v. Dyax Corp. (D. Mass and Fed. Cir.).
IP Opinion, Patent Office and Due Diligence Experience:
From 1998-2001 Ms. Joneja was a patent agent at the former intellectual property boutique Fish & Neave. There she counseled numerous biotechnology and biopharmaceutical clients and obtained extensive experience in world-wide patent prosecution, including interferences and foreign oppositions, in the area of biotechnology.
Represented Shell Oil Company, Pfizer Inc. and Dyax Corp. in connection with patent opinion work on various chemical, pharmaceutical and biopharmaceutical products.
Represented Bank of America in connection with due diligence investigation involving a potential acquisition.
